FGFR2 and cancer: Our FGFR2 mutation analysis in a series of 62 women visiting the Cancer Center at the University of Iowa combined with that of 402 TCGA cases revealed, in accordance with others,4, 6, 77 that the overall FGFR2 mutation rate in the combined cohort of 464 EC cases was approximately 10% (53/464), whereas nearly a quarter (24.2%) of our patients with EC carried 1 of the FGFR2 mutations (15/62).